Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

Nature Medicine volume 15, pages 559–565 (2009)Cite this article

An Erratum to this article was published on 01 July 2009

This article has been updated

Abstract

Many studies have shown that primary prostate cancers are multifocal1,2,3 and are composed of multiple genetically distinct cancer cell clones4,5,6. Whether or not multiclonal primary prostate cancers typically give rise to multiclonal or monoclonal prostate cancer metastases is largely unknown, although studies at single chromosomal loci are consistent with the latter case. Here we show through a high-resolution genome-wide single nucleotide polymorphism and copy number survey that most, if not all, metastatic prostate cancers have monoclonal origins and maintain a unique signature copy number pattern of the parent cancer cell while also accumulating a variable number of separate subclonally sustained changes. We find no relationship between anatomic site of metastasis and genomic copy number change pattern. Taken together with past animal and cytogenetic studies of metastasis7 and recent single-locus genetic data in prostate and other metastatic cancers8,9,10, these data indicate that despite common genomic heterogeneity in primary cancers, most metastatic cancers arise from a single precursor cancer cell. This study establishes that genomic archeology of multiple anatomically separate metastatic cancers in individuals can be used to define the salient genomic features of a parent cancer clone of proven lethal metastatic phenotype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: DNA copy number changes in mulitple anatomically separate prostate cancer samples from JHASPC subjects cluster together by subject.
Figure 2: Allele-specific DNA copy number analysis in JHASPC subject 17 reveals clonal and subclonal changes.
Figure 3: Allele-specific DNA copy number analysis in JHASPC subject 34 reveals clonal and subclonal changes.
Figure 4: Potential patterns of metastatic prostate cancer spread.

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

Change history

  • 07 July 2009

    In the version of this article initially published, some of the sample identifiers were missing from Figure 1e. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Miller, G.J. & Cygan, J.M. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J. Urol. 152, 1709–1713 (1994).

    Article  CAS  Google Scholar 

  2. Ruijter, E.T., van de Kaa, C.A., Schalken, J.A., Debruyne, F.M. & Ruiter, D.J. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J. Pathol. 180, 295–299 (1996).

    Article  CAS  Google Scholar 

  3. Aihara, M., Wheeler, T.M., Ohori, M. & Scardino, P.T. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 43, 60–66 (1994).

    Article  CAS  Google Scholar 

  4. Cheng, L. et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J. Natl. Cancer Inst. 90, 233–237 (1998).

    Article  CAS  Google Scholar 

  5. Macintosh, C.A., Stower, M., Reid, N. & Maitland, N.J. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res. 58, 23–28 (1998).

    CAS  PubMed  Google Scholar 

  6. Cheng, L. et al. Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 85, 2017–2022 (1999).

    Article  CAS  Google Scholar 

  7. Fidler, I.J. & Talmadge, J.E. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res. 46, 5167–5171 (1986).

    CAS  PubMed  Google Scholar 

  8. Kuukasjärvi, T. et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57, 1597–1604 (1997).

    PubMed  Google Scholar 

  9. Sabatino, M. et al. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis. Cancer Res. 68, 122–131 (2008).

    Article  CAS  Google Scholar 

  10. Mehra, R. et al. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res. 68, 3584–3590 (2008).

    Article  CAS  Google Scholar 

  11. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116–5121 (2001).

    Article  CAS  Google Scholar 

  12. Zhu, Y. et al. A ground truth based comparative study on clustering of gene expression data. Front. Biosci. 13, 3839–3849 (2008).

    Article  CAS  Google Scholar 

  13. Hastie, T.R., Tibshirani, T.R. & Friedman, J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 415–431 (Springer, New York, 2001).

  14. Wang, Z. et al. Optimized multilayer perceptrons for molecular classification and diagnosis using genomic data. Bioinformatics 22, 755–761 (2006).

    Article  CAS  Google Scholar 

  15. Loog, M., Duin, R. & Haeb-Umbach, R. Multiclass linear dimension reduction by weighted pairwise fisher criteria. IEEE Trans. Pattern Anal. Mach. Intell. 23, 762–766 (2001).

    Article  Google Scholar 

  16. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 133, 571–573 (1889).

    Article  Google Scholar 

  17. Nowell, P.C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).

    Article  CAS  Google Scholar 

  18. Heim, S., Mandahl, N. & Mitelman, F. Genetic convergence and divergence in tumor progression. Cancer Res. 48, 5911–5916 (1988).

    CAS  PubMed  Google Scholar 

  19. Eastham, J.A. et al. Association of p53 mutations with metastatic prostate cancer. Clin. Cancer Res. 1, 1111–1118 (1995).

    CAS  PubMed  Google Scholar 

  20. Suzuki, H. et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58, 204–209 (1998).

    CAS  PubMed  Google Scholar 

  21. Bova, G.S., Chan-Tack, K. & LeCates, W.W. Lethal metastatic human prostate cancer: a review of the literature with emphasis on autopsy studies and characteristics of metastases in Prostate Cancer: Biology, Genetics, and New Therapeutics 39–60 (Humana Press, Totowa, New Jersey, 2000).

  22. Powell, I.J. Epidemiology and pathophysiology of prostate cancer in African-American men. J. Urol. 177, 444–449 (2007).

    Article  Google Scholar 

  23. Koivisto, P. et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 57, 314–319 (1997).

    CAS  PubMed  Google Scholar 

  24. Miyoshi, Y. et al. Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. Prostate 43, 225–232 (2000).

    Article  CAS  Google Scholar 

  25. Yegnasubramanian, S. et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 64, 1975–1986 (2004).

    Article  CAS  Google Scholar 

  26. Yegnasubramanian, S. et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 68, 8954–8967 (2008).

    Article  CAS  Google Scholar 

  27. Shah, R.B. et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 64, 9209–9216 (2004).

    Article  CAS  Google Scholar 

  28. Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623–627 (1997).

    Article  CAS  Google Scholar 

  29. Vander Griend, D.J. et al. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res. 68, 9703–9711 (2008).

    Article  CAS  Google Scholar 

  30. Ellis, W.J. et al. Detection and isolation of prostate cancer cells from peripheral blood and bone marrow. Urology 61, 277–281 (2003).

    Article  Google Scholar 

  31. Vessella, R.L., Pantel, K. & Mohla, S. Tumor cell dormancy: an NCI workshop report. Cancer Biol. Ther. 6, 1496–1504 (2007).

    Article  Google Scholar 

  32. Saramäki, O.R., Porkka, K.P., Vessella, R.L. & Visakorpi, T. Genetic aberrations in prostate cancer by microarray analysis. Int. J. Cancer 119, 1322–1329 (2006).

    Article  Google Scholar 

  33. Kallioniemi, A. et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818–821 (1992).

    Article  CAS  Google Scholar 

  34. Good, P.I. Permutation, Parametric and Bootstrap Tests of Hypotheses Ch. 3 (Springer, New York, 2005).

    Google Scholar 

  35. Kowalski, J., Pagano, M. & DeGruttola, V. A Nonparametric Test of Gene Region Heterogeneity Associated With Phenotype. J. Am. Stat. Assoc. 97, 398–408 (2002).

    Article  Google Scholar 

Download references

Acknowledgements

We thank the participating men and their families who suffered through metastatic prostate cancer and nonetheless gave the gift of participation so that others might benefit. We also thank V. Sinibaldi, T.B. Smyth and G.J. Mamo for oncologic and urologic clinical support, the Johns Hopkins Pathology Autopsy Service, including B. Crain and G. Hutchins, and A. Alkula, S. Kuivanen, T. Vilkkilä-Qwick, M. Vakkuri, D. Jay, X. Yi, S. H. Hahm, K. Jeffers Keiger, S. H. Chen, P. Powers, M. Taylor, C. Kang and Partek Customer Support for technical assistance. This work, commenced in 1994, was supported in part by Pirkanmaa Cancer Foundation, Maud Kuistila Foundation, Finnish Medical Foundation, the Medical Research Fund of Tampere University Hospital, Academy of Finland, Cancer Society of Finland, Reino Lahtikari Foundation, Sigrid Juselius Foundation, CaPCURE Foundation, John and Kathe Dyson, David Koch, the US National Institutes of Health National Cancer Institute (CA92234), the Prostate Cancer Research and Education Foundation, the US Department of Defense Congressionally Directed Prostate Cancer Research Program, the Grove Foundation and the American Cancer Society.

Author information

Author notes

  1. Wennuan Liu and Sari Laitinen: These authors contributed equally to this work.

Authors and Affiliations

  1. Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA

    Wennuan Liu & Jianfeng Xu

  2. Laboratory of Cancer Genetics Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland

    Sari Laitinen & Tapio Visakorpi

  3. Laboratory of Bioinformatics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland

    Sofia Khan & Mauno Vihinen

  4. Department of Oncology Biostatistics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Jeanne Kowalski

  5. Department of Electrical and Computer Engineering, Computational Bioinformatics and Bio-imaging Laboratory, Virginia Polytechnic Institute and State University, Arlington, Virginia, USA

    Guoqiang Yu, Li Chen & Yue Wang

  6. Department of Urology Genetic Medicine and Health Sciences Informatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Charles M Ewing, Jun Luo, William B Isaacs & G Steven Bova

  7. Department of Oncology, Genetic Medicine and Health Sciences Informatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Mario A Eisenberger, Michael A Carducci, William G Nelson, Srinivasan Yegnasubramanian, Jun Luo, William B Isaacs & G Steven Bova

  8. Departments of Pathology, Project to Eliminate Lethal Prostate Cancer Laboratory, Genetic Medicine and Health Sciences Informatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    G Steven Bova

Authors
  1. Wennuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sari Laitinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sofia Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mauno Vihinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeanne Kowalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guoqiang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Charles M Ewing
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mario A Eisenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael A Carducci
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. William G Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Srinivasan Yegnasubramanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jun Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yue Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jianfeng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. William B Isaacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Tapio Visakorpi
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. G Steven Bova
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

W.L. performed and analyzed Affy6 assays and contributed to the manuscript and direction of study; S.L. performed and analyzed cCGH assays and contributed to the manuscript; S.K. performed statistical analysis of cCGH data and contributed to the manuscript; M.V. supervised statistical analysis of cCGH data and contributed to the manuscript; J.K. supervised and directed statistical analysis of cCGH and Affy6 data and contributed to the manuscript; G.Y. and L.C. performed statistical analysis of cCGH and Affy6 data and contributed to the manuscript; C.M.E. performed TMPRSS2-ERG transcript assays and contributed to the manuscript; M.A.E. and M.A.C. provided clinical support for the study; W.G.N. contributed to the manuscript and the analysis of chemotherapy data; S.Y. contributed to the manuscript and the direction of the study; J.L. contributed to the TMPRSS2-ERG transcript analysis and contributed to the manuscript; Y.W. supervised and directed cCGH and Affy6 data analysis and contributed to the manuscript; J.X. supervised Affy6 data collection and analysis and contributed to the direction of the study; W.B.I. supervised TMPRSS2-ERG transcript analysis and contributed to the manuscript and the direction of the study; T.V. supervised and interpreted cCGH data collection and contributed to the manuscript and the direction of the study; and G.S.B. founded and directed the autopsy project, directed the study, analyzed data and wrote the manuscript.

Corresponding author

Correspondence to G Steven Bova.

Supplementary information

Supplementary Text and Figures

Supplementary Figs. 1–14, Supplementary Tables 1–11 and Supplementary Methods (PDF 902 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, W., Laitinen, S., Khan, S. et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15, 559–565 (2009). https://doi.org/10.1038/nm.1944

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.1944

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing